Coronary microvascular dysfunction in a porcine model of early atherosclerosis and diabetes

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H85-94. doi: 10.1152/ajpheart.00311.2011. Epub 2011 Oct 7.

Abstract

Detailed evaluation of coronary function early in diabetes mellitus (DM)-associated coronary artery disease (CAD) development is difficult in patients. Therefore, we investigated coronary conduit and small artery function in a preatherosclerotic DM porcine model with type 2 characteristics. Streptozotocin-induced DM pigs on a saturated fat/cholesterol (SFC) diet (SFC + DM) were compared with control pigs on SFC and standard (control) diets. SFC + DM pigs showed DM-associated metabolic alterations and early atherosclerosis development in the aorta. Endothelium-dependent vasodilation to bradykinin (BK), with or without blockade of nitric oxide (NO) synthase, endothelium-independent vasodilation to an exogenous NO-donor (S-nitroso-N-acetylpenicillamine), and vasoconstriction to endothelin (ET)-1 with blockade of receptor subtypes, were assessed in vitro. Small coronary arteries, but not conduit vessels, showed functional alterations including impaired BK-induced vasodilatation due to loss of NO (P < 0.01 vs. SFC and control) and reduced vasoconstriction to ET-1 (P < 0.01 vs. SFC and control), due to a decreased ET(A) receptor dominance. Other vasomotor responses were unaltered. In conclusion, this model demonstrates specific coronary microvascular alterations with regard to NO and ET-1 systems in the process of early atherosclerosis in DM. In particular, the altered ET-1 system correlated with hyperglycemia in atherogenic conditions, emphasizing the importance of this system in DM-associated CAD development.

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Bradykinin / pharmacology
  • Coronary Artery Disease / etiology*
  • Coronary Artery Disease / metabolism
  • Coronary Artery Disease / physiopathology
  • Coronary Vessels / drug effects
  • Coronary Vessels / metabolism
  • Coronary Vessels / physiopathology*
  • Diabetes Mellitus, Experimental / complications*
  • Diabetes Mellitus, Experimental / metabolism
  • Diabetes Mellitus, Experimental / physiopathology
  • Diabetic Angiopathies / etiology*
  • Diabetic Angiopathies / metabolism
  • Diabetic Angiopathies / physiopathology
  • Disease Progression
  • Dose-Response Relationship, Drug
  • Endothelin-1 / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / physiopathology*
  • Male
  • Nitric Oxide / metabolism
  • Nitric Oxide Donors / pharmacology
  • Receptors, Endothelin / drug effects
  • Receptors, Endothelin / metabolism
  • S-Nitroso-N-Acetylpenicillamine / pharmacology
  • Swine
  • Time Factors
  • Vasoconstriction* / drug effects
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation* / drug effects
  • Vasodilator Agents / pharmacology

Substances

  • Blood Glucose
  • Endothelin-1
  • Nitric Oxide Donors
  • Receptors, Endothelin
  • Vasoconstrictor Agents
  • Vasodilator Agents
  • Nitric Oxide
  • S-Nitroso-N-Acetylpenicillamine
  • Bradykinin